Clinical Importance of Metalloproteinases and Their Inhibitors

Annals of the New York Academy of Sciences

Volumn 732, Issue 1, 1994, Pages 1-10

  KRANE, STEPHEN M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGENASE; METALLOPROTEINASE; PROTEINASE INHIBITOR; STROMELYSIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTHROPATHY; CELL DAMAGE; CONFERENCE PAPER; ENZYME SYNTHESIS; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEINASE INHIBITION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SPONTANEOUS MUTATION; SYNOVIUM;

ANIMALIA;

EID: 0028641152     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1994.tb24719.x     Document Type: Article

References (64)

1. Collagen biology: Structure, degradation and disease
2. Catabolism and turnover of collagens: Collagenases
3. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
4. The matrix metalloproteinases and their inhibitors
5. Matrixmetalloproteinases: A review
6. Mechanisms of tissue destruction in rheumatoid arthritis. In Arthritis and Allied Conditions. A Textbook of Rheumatology
7. Families of metalloendopeptidases and their relationships
8. The tissue metalloproteinase family and the inhibitor TIMP: A study using DNAs and recombinant proteins
9. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
10. Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of active‐site zinc complex in latency and a “cysteine switch mechanism for activation
11. Sequence specificity of human skin fibroblast collagenase
12. Proteolytic activities of human fibroblast collagenase: Hydrolysis of a broad range of substrates at a single active site
13. Sequence specificities of human fibroblast and neutrophil collagenases
14. The collagen substrate specificity of human neutrophil collagenase
15. Human neutrophil collagenase
16. Human fibroblast collagenase
17. Comparison of human stromelysin and collagenase by cloning and sequence analysis
18. Cloning and sequencing of mouse collagenase cDNA
19. The role of the C‐terminal domain in collagenase and stromelysin specificity
20. Vertebrate collagenases
21. The activation of human skin fibroblast collagenase
22. Secreted proteases
23. Generation of collagenase‐resistant collagen by site‐directed mutagenesis of murine proα1(I) collagen gene
24. Site‐directed mutagenesis of type I collagen: Effect on susceptibility to collagenase
25. Susceptibility of type I collagen containing mutated α1(I) chains to cleavage by human neutrophil collagenase
26. Collagenases
27. Regulation of the mammalian collagenases
28. Mammalian collagenase
29. Mechanisms of matrix degradation in rheumatoid arthritis
30. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium
31. Expression of metalloproteinases and metalloproteinase inhibitors in human arthritic synovium
32. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA‐DR) in rheumatoid arthritis and osteoarthritis synovium
33. The interaction of immunocompetent cells and chronic inflammation as exemplified by rheumatoid arthritis
34. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1
35. The degradation of type II collagen in rheumatoid arthritis: An immunoelectron microscopic study
36. Collagenase production by synovial fibroblasts treated with phorbol myristate acetate
37. Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts
38. 12‐O‐tetradecanoyl‐phorbol‐13‐acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′‐flanking region
39. Phorbol ester‐inducible genes contain a common cis element recognized by a TPA‐modulated trans‐acting factor
40. Purified transcription factor AP‐1 interacts with TPA‐inducible enhancer elements
41. Fos and Jun: The AP‐1 connection
42. The product of a fos‐related gene, fra‐1, binds cooperatively to the AP‐1 site with Jun: transcription factor AP‐1 is comprised of multiple protein complexes
43. Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos‐cJun heterodimers
44. Parallel association of fos and jun leucine zippers juxtaposes DNA binding domains
45. Scissors‐grip model for DNA recognition by a family of leucine zipper proteins
46. Control of transcription factors by signal transduction pathways: The beginning of the end
47. Increases in levels of procollagenase messenger RNA in cultured fibroblasts induced by human recombinant interleukin 1β or serum follow c‐jun expression and are dependent on new protein synthesis
48. Increases in levels of procollagenase mRNA in human fibroblasts induced by interleukin‐1, tumor necrosis factor‐α, or serum follow c‐jun expression and are dependent on new protein synthesis
49. A point mutation uncouples human interleukin‐1β biological activity and receptor binding
50. An interleukin 1β point mutant demonstrates that junsol;fos expression is not sufficient for fibroblast metalloproteinase expression
51. Mutations in collagen genes: Causes of rare and some common diseases in humans
52. Gene targeting
53. Disruption of the protooncogene int‐2 in mouse embryo‐derived stem cells: A general strategy for targeting mutations to non‐selectable genes
54. Germ‐line transmission of a collagenase‐resistant Collal gene produced by homologous recombination in embryonic stem cells
55. On the size of the active site in proteases I. Papain.
56. Rat collagenase
57. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption
58. Hormonal regulation of the production of collagenase and a collagenase inhibitor activity by rat osteogenic sarcoma cells
59. Bone‐resorbing agents promote and interferon‐γ inhibits bone cell collagenase production
60. Relative roles of collagenase and lysosomal cysteine‐proteinases in bone resorption
61. Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs
62. Osteopetrosis: Multiple pathways for the interruption of osteoclast function